The aortic valve replacement devices market size has grown rapidly in recent years. It will grow from $8.85 billion in 2025 to $9.75 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to growth in aging population with valvular diseases, expansion of cardiac surgery capabilities, increased diagnosis of aortic stenosis, early adoption of surgical valve replacements, improvements in cardiovascular imaging.
The aortic valve replacement devices market size is expected to see rapid growth in the next few years. It will grow to $14.51 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing preference for transcatheter procedures, rising investments in structural heart programs, growing demand for outpatient cardiac interventions, expansion of advanced biomaterials usage, increasing procedural success rates. Major trends in the forecast period include increasing adoption of minimally invasive valve replacement, rising use of transcatheter valve technologies, growing demand for self-expandable valves, expansion of patient-specific valve designs, enhanced focus on long-term valve durability.
The increasing number of valve replacement surgeries is anticipated to drive the expansion of the aortic valve replacement devices market in the coming years. Valve replacement surgeries are medical procedures carried out to repair or substitute damaged heart valves to restore normal blood circulation and enhance cardiac function. The growth in valve replacement surgeries, driven by a rise in age-related heart valve disorders, is contributing to a higher demand for surgical interventions aimed at managing deteriorating valve function and preventing complications. Aortic valve replacement devices facilitate these surgeries by allowing safer and more effective valve repair or replacement, improving procedural outcomes, and supporting broader surgical adoption. For example, in June 2025, according to the British Heart Foundation, a UK-based cardiovascular research charity, over 13,034 aortic valve replacement (AVR) procedures and nearly 7,695 transcatheter aortic valve implantation (TAVI) procedures were conducted in the United Kingdom in 2022/23, with TAVI procedures on the rise, reflecting growing adoption of less invasive valve replacement methods. Therefore, the increasing number of valve replacement surgeries is propelling the growth of the aortic valve replacement devices market.
Leading companies operating in the aortic valve replacement devices market are focusing on advanced innovations, such as three radiopaque vision markers to enhance procedural visibility, improve deployment accuracy, and enable precise valve positioning during transcatheter implantation procedures. Three radiopaque vision markers are clearly visible reference points integrated into a medical device that enhance fluoroscopic visibility, helping clinicians accurately position and deploy the device during minimally invasive procedures. For example, in January 2025, Abbott Laboratories, the US-based healthcare company, launched Navitor Vision in India, the latest version of its transcatheter aortic valve implantation/replacement (TAVI/TAVR) system. The device is designed to treat patients with symptomatic severe aortic stenosis who are at high or extreme surgical risk. Navitor Vision features three radiopaque vision markers for enhanced visibility during implantation, a dynamic sealing cuff to reduce blood leakage, and is delivered using Abbott’s FlexNav delivery system for precise, minimally invasive valve placement. It provides a less invasive alternative to surgical aortic valve replacement, improving outcomes and accessibility for high-risk patients.
In August 2024, Edwards Lifesciences Corporation, a US-based technology company, acquired JC Medical for an undisclosed amount. Through this acquisition, Edwards Lifesciences aims to broaden its transcatheter aortic valve replacement (TAVR) portfolio by incorporating JC Medical’s J Valve System, enhancing treatment options for severe aortic regurgitation, and reinforcing its global leadership in structural heart therapies. JC Medical Inc. is a US-based company specializing in the development of transcatheter aortic valve replacement devices, including the J Valve System, and advancing innovative solutions for treating severe aortic regurgitation and other structural heart conditions.
Major companies operating in the aortic valve replacement devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Bracco SpA, Biotronik SE & Co. KG, LivaNova Plc, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Artivion Inc., LifeTech Scientific Corporation, TTK Healthcare Limited, Braile Biomedica, Venus Medtech Inc., SMT Pvt Ltd, JenaValve Technology Inc., Peijia Medical Limited, CryoLife Inc., CorLife, and Colibri Heart Valve LLC.
Tariffs are influencing the aortic valve replacement devices market by increasing costs of imported biomaterials, precision metal frames, catheter systems, and advanced manufacturing equipment. Medical device manufacturers in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces cost pressures on device exports. These tariffs are increasing device prices and procurement costs for healthcare providers. At the same time, they are encouraging localized device manufacturing, regional supplier partnerships, and innovation in cost-optimized valve replacement technologies.
The aortic valve replacement devices market research report is one of a series of new reports that provides aortic valve replacement devices market statistics, including aortic valve replacement devices industry global market size, regional shares, competitors with a aortic valve replacement devices market share, detailed aortic valve replacement devices market segments, market trends and opportunities, and any further data you may need to thrive in the aortic valve replacement devices industry. This aortic valve replacement devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Aortic valve replacement devices are medical products developed to substitute a damaged or malfunctioning aortic valve in order to restore normal heart function. They facilitate regulated and efficient blood flow from the heart to the aorta by mimicking the operation of a natural valve. These devices combine engineered valve structures with advanced implantation technologies to deliver dependable performance and long-term cardiovascular support.
The primary product types of aortic valve replacement devices include balloon-expandable, self-expandable, mechanically expandable, and aortic regurgitation devices. Balloon-expandable devices are valves mounted on a balloon catheter that is inflated at the treatment site to replace a diseased aortic valve. These devices are manufactured using leaflet materials such as bovine pericardium and porcine pericardium, along with frame materials including cobalt-chromium and nitinol, and are used by end users across inpatient facilities and outpatient facilities.
The aortic valve replacement devices consists of sales of surgical aortic valves, transcatheter aortic valve replacement (TAVR) systems, balloon-expandable valves, self-expandable valves, sutureless valves, and related implantation accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and medical facilities) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The aortic valve replacement devices market size is expected to see rapid growth in the next few years. It will grow to $14.51 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to increasing preference for transcatheter procedures, rising investments in structural heart programs, growing demand for outpatient cardiac interventions, expansion of advanced biomaterials usage, increasing procedural success rates. Major trends in the forecast period include increasing adoption of minimally invasive valve replacement, rising use of transcatheter valve technologies, growing demand for self-expandable valves, expansion of patient-specific valve designs, enhanced focus on long-term valve durability.
The increasing number of valve replacement surgeries is anticipated to drive the expansion of the aortic valve replacement devices market in the coming years. Valve replacement surgeries are medical procedures carried out to repair or substitute damaged heart valves to restore normal blood circulation and enhance cardiac function. The growth in valve replacement surgeries, driven by a rise in age-related heart valve disorders, is contributing to a higher demand for surgical interventions aimed at managing deteriorating valve function and preventing complications. Aortic valve replacement devices facilitate these surgeries by allowing safer and more effective valve repair or replacement, improving procedural outcomes, and supporting broader surgical adoption. For example, in June 2025, according to the British Heart Foundation, a UK-based cardiovascular research charity, over 13,034 aortic valve replacement (AVR) procedures and nearly 7,695 transcatheter aortic valve implantation (TAVI) procedures were conducted in the United Kingdom in 2022/23, with TAVI procedures on the rise, reflecting growing adoption of less invasive valve replacement methods. Therefore, the increasing number of valve replacement surgeries is propelling the growth of the aortic valve replacement devices market.
Leading companies operating in the aortic valve replacement devices market are focusing on advanced innovations, such as three radiopaque vision markers to enhance procedural visibility, improve deployment accuracy, and enable precise valve positioning during transcatheter implantation procedures. Three radiopaque vision markers are clearly visible reference points integrated into a medical device that enhance fluoroscopic visibility, helping clinicians accurately position and deploy the device during minimally invasive procedures. For example, in January 2025, Abbott Laboratories, the US-based healthcare company, launched Navitor Vision in India, the latest version of its transcatheter aortic valve implantation/replacement (TAVI/TAVR) system. The device is designed to treat patients with symptomatic severe aortic stenosis who are at high or extreme surgical risk. Navitor Vision features three radiopaque vision markers for enhanced visibility during implantation, a dynamic sealing cuff to reduce blood leakage, and is delivered using Abbott’s FlexNav delivery system for precise, minimally invasive valve placement. It provides a less invasive alternative to surgical aortic valve replacement, improving outcomes and accessibility for high-risk patients.
In August 2024, Edwards Lifesciences Corporation, a US-based technology company, acquired JC Medical for an undisclosed amount. Through this acquisition, Edwards Lifesciences aims to broaden its transcatheter aortic valve replacement (TAVR) portfolio by incorporating JC Medical’s J Valve System, enhancing treatment options for severe aortic regurgitation, and reinforcing its global leadership in structural heart therapies. JC Medical Inc. is a US-based company specializing in the development of transcatheter aortic valve replacement devices, including the J Valve System, and advancing innovative solutions for treating severe aortic regurgitation and other structural heart conditions.
Major companies operating in the aortic valve replacement devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Edwards Lifesciences Corporation, Bracco SpA, Biotronik SE & Co. KG, LivaNova Plc, Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, Artivion Inc., LifeTech Scientific Corporation, TTK Healthcare Limited, Braile Biomedica, Venus Medtech Inc., SMT Pvt Ltd, JenaValve Technology Inc., Peijia Medical Limited, CryoLife Inc., CorLife, and Colibri Heart Valve LLC.
Tariffs are influencing the aortic valve replacement devices market by increasing costs of imported biomaterials, precision metal frames, catheter systems, and advanced manufacturing equipment. Medical device manufacturers in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces cost pressures on device exports. These tariffs are increasing device prices and procurement costs for healthcare providers. At the same time, they are encouraging localized device manufacturing, regional supplier partnerships, and innovation in cost-optimized valve replacement technologies.
The aortic valve replacement devices market research report is one of a series of new reports that provides aortic valve replacement devices market statistics, including aortic valve replacement devices industry global market size, regional shares, competitors with a aortic valve replacement devices market share, detailed aortic valve replacement devices market segments, market trends and opportunities, and any further data you may need to thrive in the aortic valve replacement devices industry. This aortic valve replacement devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Aortic valve replacement devices are medical products developed to substitute a damaged or malfunctioning aortic valve in order to restore normal heart function. They facilitate regulated and efficient blood flow from the heart to the aorta by mimicking the operation of a natural valve. These devices combine engineered valve structures with advanced implantation technologies to deliver dependable performance and long-term cardiovascular support.
The primary product types of aortic valve replacement devices include balloon-expandable, self-expandable, mechanically expandable, and aortic regurgitation devices. Balloon-expandable devices are valves mounted on a balloon catheter that is inflated at the treatment site to replace a diseased aortic valve. These devices are manufactured using leaflet materials such as bovine pericardium and porcine pericardium, along with frame materials including cobalt-chromium and nitinol, and are used by end users across inpatient facilities and outpatient facilities.
The aortic valve replacement devices consists of sales of surgical aortic valves, transcatheter aortic valve replacement (TAVR) systems, balloon-expandable valves, self-expandable valves, sutureless valves, and related implantation accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and medical facilities) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Aortic Valve Replacement Devices Market Characteristics
3. Aortic Valve Replacement Devices Market Supply Chain Analysis
4. Global Aortic Valve Replacement Devices Market Trends and Strategies
5. Aortic Valve Replacement Devices Market Analysis Of End Use Industries
7. Global Aortic Valve Replacement Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Aortic Valve Replacement Devices Total Addressable Market (TAM) Analysis for the Market
9. Aortic Valve Replacement Devices Market Segmentation
10. Aortic Valve Replacement Devices Market Regional and Country Analysis
11. Asia-Pacific Aortic Valve Replacement Devices Market
12. China Aortic Valve Replacement Devices Market
13. India Aortic Valve Replacement Devices Market
14. Japan Aortic Valve Replacement Devices Market
15. Australia Aortic Valve Replacement Devices Market
16. Indonesia Aortic Valve Replacement Devices Market
17. South Korea Aortic Valve Replacement Devices Market
18. Taiwan Aortic Valve Replacement Devices Market
19. South East Asia Aortic Valve Replacement Devices Market
20. Western Europe Aortic Valve Replacement Devices Market
21. UK Aortic Valve Replacement Devices Market
22. Germany Aortic Valve Replacement Devices Market
23. France Aortic Valve Replacement Devices Market
24. Italy Aortic Valve Replacement Devices Market
25. Spain Aortic Valve Replacement Devices Market
26. Eastern Europe Aortic Valve Replacement Devices Market
27. Russia Aortic Valve Replacement Devices Market
28. North America Aortic Valve Replacement Devices Market
29. USA Aortic Valve Replacement Devices Market
30. Canada Aortic Valve Replacement Devices Market
31. South America Aortic Valve Replacement Devices Market
32. Brazil Aortic Valve Replacement Devices Market
33. Middle East Aortic Valve Replacement Devices Market
34. Africa Aortic Valve Replacement Devices Market
36. Aortic Valve Replacement Devices Market Competitive Landscape and Company Profiles
37. Aortic Valve Replacement Devices Market Other Major and Innovative Companies
41. Aortic Valve Replacement Devices Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Aortic Valve Replacement Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses aortic valve replacement devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for aortic valve replacement devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aortic valve replacement devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Balloon-Expandable; Self-Expandable; Mechanically Expandable; Aortic Regurgitation2) By Leaflet Material: Bovine Pericardium; Porcine Pericardium
3) By Frame Material: Cobalt-Chromium; Nitinol
4) By End-Use: Inpatient Facilities; Outpatient Facilities
Subsegments:
1) By Balloon-Expandable: Balloon Pre-Dilation; Balloon Post-Dilation; Balloon Valves2) By Self-Expandable: Supra-Annular Valves; Intra-Annular Valves; Resheathable Valves
3) By Mechanically Expandable: Mechanically Adjustable Valves; Radial Force Valves; Repositionable Valves
4) By Aortic Regurgitation: Surgical Valve Replacement; Transcatheter Valve Replacement; Repair Devices
Companies Mentioned: Abbott Laboratories; Medtronic Plc; Boston Scientific Corporation; Edwards Lifesciences Corporation; Bracco SpA; Biotronik SE & Co. KG; LivaNova Plc; Lepu Medical Technology Co. Ltd.; MicroPort Scientific Corporation; Artivion Inc.; LifeTech Scientific Corporation; TTK Healthcare Limited; Braile Biomedica; Venus Medtech Inc.; SMT Pvt Ltd; JenaValve Technology Inc.; Peijia Medical Limited; CryoLife Inc.; CorLife; and Colibri Heart Valve LLC.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Aortic Valve Replacement Devices market report include:- Abbott Laboratories
- Medtronic Plc
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- Bracco SpA
- Biotronik SE & Co. KG
- LivaNova Plc
- Lepu Medical Technology Co. Ltd.
- MicroPort Scientific Corporation
- Artivion Inc.
- LifeTech Scientific Corporation
- TTK Healthcare Limited
- Braile Biomedica
- Venus Medtech Inc.
- SMT Pvt Ltd
- JenaValve Technology Inc.
- Peijia Medical Limited
- CryoLife Inc.
- CorLife
- and Colibri Heart Valve LLC.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | March 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.75 Billion |
| Forecasted Market Value ( USD | $ 14.51 Billion |
| Compound Annual Growth Rate | 10.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
